VersaCross Access Solution provides exchangeless access-to-delivery of left heart therapy devices.
Clinical highlights
Randomized comparison of a radiofrequency wire versus a radiofrequency needle system for transseptal puncture
25% faster
32% faster
30% lower
Publication summaries
June 2023, Doshi et al.
VersaCross transseptal system for mitral transcatheter edge-to-edge repair with the PASCAL repair platform
When compared to a standard mechanical needle-based workflow, the VersaCross™ RF Wire-based workflow enabled faster TSP (transseptal puncture) and PASCAL Precision™ Transcatheter Valve Repair System deployment, with fewer exchanges required to streamline mitral transcatheter edge-to-edge repair (M-TEER) procedures.
November 2022, Dewland et al
Randomized comparison of a radiofrequency wire versus a radiofrequency needle system for transseptal puncture
RF wire-based transseptal workflow resulted in a faster time to transseptal puncture, with fewer exchanges for RF ablation, compared to an RF needle-based workflow.
February 2022, Demo et al.
Fluoroless left atrial access for radiofrequency and cryoballoon ablations using a novel radiofrequency transseptal wire
The VersaCross RF Transseptal Solution enabled fluoroless transseptal puncture in ablation procedures, with average transseptal puncture time under 20 minutes and zero exchanges required for transseptal puncture.
January 2021, Inohara et al.
VersaCross radiofrequency system reduces time to left atrial access versus conventional mechanical needle
LAAC sheath delivery was two times faster using the VersaCross™ RF Transseptal Solution than the conventional workflow.
November 2020, Asgar et al.
Initial clinical experience with VersaCross transseptal system for transcatheter mitral valve repair
The VersaCross Radiofrequency RF Transseptal Solution enabled MitraClip™ Guide delivery in under 7.5 minutes.
